Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022
08:03am, Monday, 25'th Apr 2022
The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET
This Hidden Stock Exploded by 190% in a Day. Is It a Buy?
10:30am, Saturday, 16'th Apr 2022 The Motley Fool
Its drug for severe COVID-19 could be a smash hit, based on recent clinical trial findings.
Catalyst Pharmaceutical (CPRX) is a Top-Ranked Momentum Stock: Should You Buy?
11:17am, Wednesday, 06'th Apr 2022
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
7 Smart Stocks to Buy Now Under $10
06:41pm, Tuesday, 05'th Apr 2022
There are always good stocks to buy somewhere. What you should be focused on is finding the smart stocks that add value to your portfolio.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
02:00pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Marinus (MRNS) Gets FDA Nod for Ztalmy in Rare Genetic Disorder
01:52pm, Monday, 21'st Mar 2022 Zacks Investment Research
The FDA approves Marinus' (MRNS) Ztalmy (ganaxolone) to treat seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. The company's shares gain following the announcement.
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2021 Results - Earnings Call Transcript
04:36pm, Thursday, 17'th Mar 2022
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2021 Results - Earnings Call Transcript
Catalyst (CPRX) Q4 Earnings Lag Estimates, Revenues Rise Y/Y
02:39pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Catalyst's (CPRX) fourth-quarter 2021 earnings miss estimates while revenues slightly beat the mark.
Catalyst (CPRX) Q4 Earnings Lag Estimates, Revenues Rise Y/Y
12:02pm, Thursday, 17'th Mar 2022
Catalyst's (CPRX) fourth-quarter 2021 earnings miss estimates while revenues slightly beat the mark.
Catalyst Pharmaceutical (CPRX) Q4 Earnings Lag Estimates
09:45pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Catalyst (CPRX) delivered earnings and revenue surprises of -25% and 0.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharmaceuticals GAAP EPS of $0.09 misses by $0.03, revenue of $38.31M beats by $0.13M
08:23pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Catalyst Pharmaceuticals press release (CPRX): Q4 GAAP EPS of $0.09 misses by $0.03.Revenue of $38.31M (+23.5% Y/Y) beats by $0.13M.Shares -0.13%.Strong 2022 Revenue Growth…
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
08:21pm, Wednesday, 16'th Mar 2022 GlobeNewswire Inc.
Total 2021 Revenues Increased Approximately 18% YoY to $141 Million
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
08:21pm, Wednesday, 16'th Mar 2022 GlobeNewswire
Total 2021 Revenues Increased Approximately 18% YoY to $141 Million
Catalyst Pharmaceutical (CPRX) Q4 Earnings Lag Estimates
06:48pm, Wednesday, 16'th Mar 2022
Catalyst (CPRX) delivered earnings and revenue surprises of -25% and 0.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
01:40pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
